[Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in earlystage cervical cancer. Ouyang F, Liu J, Xia M, Lin C, et al. Oncol Rep 2021;45.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ouyang F, Liu J, Xia M, Lin C, et al. [Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in earlystage cervical cancer. Oncol Rep 2021;45.
PMID: 33882645